The effects of SRL (0

Copyright information:Taken from "Sirolimus inhibits key events of restenosis in vitro/ex vivo: evaluation of the clinical relevance of the data by SI/MPL- and SI/DES-ratio's"http://www.biomedcentral.com/1471-2261/7/15BMC Cardiovascular Disorders 2007;7():15-15.Published online 11 May 2007PMCID:PMC1878500.01, 0.1, 1, 10, 100, 1000 ng/ml) on migration of HCMSMC are demonstrated. A significant inhibition of cell migration was detected after adding of SRL in concentrations ≥ 0.1 ng/ml (* = p < 0.5; ** = p < 0.01; *** = p < 0.001; SI/MPL-ratio ≥ 0.016; SI/DES-ratio ≥ 1.3 × 10).